98%
921
2 minutes
20
Sanders, DJ, Murray, MS, McFadden, BA, Chandler, AJ, Walker, AJ, Bozzini, BN, Cintineo, HP, Bello, ML, Arent, MA, and Arent, SM. The effects of a semester of preprofessional dance training on biomarkers and performance variables in elite adolescent ballet dancers. J Strength Cond Res XX(X): 000-000, 2025-Early sport specialization exposes young athletes to high volumes of training. More knowledge is needed regarding the physiologic changes that may occur, particularly identifying differences between sexes. The purpose of this study was to evaluate biomarkers and performance changes in elite, preprofessional ballet dancers from the same training program. Male (N = 10) and female (N = 13) dancers participated in blood draws at the beginning of their semester (T1) and every 4 weeks thereafter (T2-T5). Performance was assessed pre- and postsemester (e.g., body composition, vertical jump, and V̇o2max). Repeated measures multivariate analysis of variance assessed performance and biomarker responses throughout the semester (p < 0.05). Sex-by-time interactions were observed for sex-hormone binding globulin, free cortisol, follicle stimulating hormone, and omega 6:3 ratio (p < 0.05). Sex effects were found in free triiodothyronine, testosterone, estradiol, growth hormone, creatine kinase (CK), percentage transferrin saturation, ferritin, and all performance tests (p < 0.05). Female dancers experienced further time effects in free thyroxine, follicle stimulating hormone, tumor necrosis factor alpha, omega 6:3 ratio, iron, percentage transferrin saturation, and ferritin (p < 0.05). Male dancers experienced further time effects in total triiodothyronine, total and free cortisol, CK, tumor necrosis factor alpha, vitamin D, percentage transferrin saturation, and ferritin (p < 0.05). Despite similar training, differential responses were observed between male and female dancers, particularly with regard to cortisol and hematologic markers. Adequate monitoring programs can help identify sex differences in response to training demands. Performance staff should account for and address these sex differences to enhance recovery outcomes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1519/JSC.0000000000005219 | DOI Listing |
Geroscience
September 2025
Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
This study aims to investigate the predictive value of combined phenotypic age and phenotypic age acceleration (PhenoAgeAccel) for benign prostatic hyperplasia (BPH) and develop a machine learning-based risk prediction model to inform precision prevention and clinical management strategies. The study analyzed data from 784 male participants in the US National Health and Nutrition Examination Survey (NHANES, 2001-2008). Phenotypic age was derived from chronological age and nine serum biomarkers.
View Article and Find Full Text PDFJ Cancer Res Clin Oncol
September 2025
Division of Gastroenterology, Department of Medicine, Asahikawa Medical University, Asahikawa, Japan.
Purpose: Next-generation sequencing (NGS) has revolutionized cancer treatment by enabling comprehensive cancer genomic profiling (CGP) to guide genotype-directed therapies. While several prospective trials have demonstrated varying outcomes with CGP in patients with advanced solid tumors, its clinical utility in colorectal cancer (CRC) remains to be evaluated.
Methods: We conducted a prospective observational study of CGP in our hospital between September 2019 and March 2024.
Cancer Immunol Immunother
September 2025
Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Whole blood (WB) transcriptomics offers a minimal-invasive method to assess patients' immune system. This study aimed to identify transcriptional patterns in WB associated with clinical outcomes in patients treated with immune checkpoint inhibitors (ICIs). We performed RNA-sequencing on pre-treatment WB samples from 145 patients with advanced cancer.
View Article and Find Full Text PDFMol Psychiatry
September 2025
National Center for PTSD, Behavioral Science Division, VA Boston Healthcare System, Boston, MA, 02130, USA.
Glial fibrillary acidic protein (GFAP) is an astrocytic marker that can be assessed in blood using single molecule array technology. Recent studies suggest that individuals with posttraumatic stress disorder (PTSD) have suppressed circulating levels of this CNS biomarker. This study examined the hypothesis that PTSD and plasma GFAP levels share common genetic and epigenetic pathways.
View Article and Find Full Text PDFCancer Immunol Immunother
September 2025
Department of Gastric Surgery, Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Hangzhou, 310022, Zhejiang, China.
Objectives: To evaluate the efficacy of combining PD-1 inhibitors with chemotherapy in conversion therapy for patients with stage IV gastric cancer and to determine the populations most likely to benefit from this regimen.
Methods: Data from patients with stage IV gastric cancer who received conversion therapy with PD-1 inhibitors combined with chemotherapy between January 2018 and December 2022 at multiple centers were retrospectively reviewed. Patients who underwent conversion surgery were categorized into a surgery group, while those who did not were placed into a palliative group.